Navigation Links
Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
Date:10/8/2008

fluenza vaccine generated broader, more balanced antibody responses than unformulated vaccine, and also generated influenza-specific T-cell responses. Adjusting the ratio of Vaxfectin(R) to vaccine drove substantial increases in either antibody or T-cell responses, without reducing the other type of response, compared with unformulated vaccine. The ability to favor primarily antibody or T-cell responses could provide important advantages in developing vaccines for specific applications.

H5N1 Pandemic Influenza Vaccine Phase 1 Trial Update

Vical reported in July that the company's Vaxfectin(R)-formulated H5N1 pandemic influenza DNA vaccines achieved potentially protective levels of antibody responses (H5 hemagglutination inhibition, or HI, titers of at least 40 and at least a four-fold increase from baseline) in at least 50% and up to 67% of evaluable subjects in the higher dose cohorts in a 100-subject Phase 1 trial.

Following injections at Days 0 and 21, responses peaked by Day 56, and more than 90% of the responders had sustained responses through the last measurement (Day 84) at the time of the preliminary analysis. Expanded data presented today shows that in the two cohorts receiving the highest H5 DNA dose (1 mg), 80% to 100% of the responders had sustained responses through Day 182. Similar results for a vaccine deployed during the early stages of a pandemic outbreak could provide substantial protection to the at-risk population and potentially alter the course of the pandemic.

These results support further development of Vaxfectin(R)-formulated DNA vaccines, and could position them as potential alternatives to conventional vaccines. DNA vaccines are fundamentally different from conventional vaccines because they do not contain any part of the virus itself, and may offer compelling advantages in response to a pandemic outbreak because of significantly reduced development and manufacturing times. Vical is currently seeking funding to
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
2. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
3. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
4. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
5. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
6. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
7. Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
8. New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
9. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
10. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... SHENZHEN, China, Nov. 26, 2014 China Nepstar ... the "Company"), a leading retail drugstore chain in China ... announced its unaudited financial results for the third quarter ... ended September 30, 2014: , Same store sales increased ... , Revenue increased by 8.1% to RMB738.3 million (US$120.3 ...
(Date:11/24/2014)... , Nov. 24, 2014 Luoxis Diagnostics, ... MKT: AMPE), today announced the presentation of three ... System as a broadly applicable and robust research ... the body in response to injury, illness, or ... in collaboration with Luoxis, academic and pharmaceutical research ...
(Date:11/24/2014)... CLEVELAND , Nov. 24, 2014  Surgical Theater, ... at the November 24 th opening of ... IRCCS Istituto Neurologico Nazionale "C. Besta." The SuRgical Planner ... be showcased at the event for their 3D navigation ... Dr. Joshua Bederson , Professor and Chair, Department ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 2Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 4Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 5Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3
... 20, 2011 Robbins & Myers, Inc. (NYSE: ... first quarter fiscal 2012 ending November 30, 2011 before the ... 9:00 a.m., CT / 10:00 a.m., ET on January 6.  ... J. Brown, Interim Chief Financial Officer & Corporate Controller, will ...
... HACKENSACK, N.J., Dec. 20, 2011 In an ... error rates, HackensackUMC recently announced the implementation of ... SurgiCount Safety-Sponge®  is a product of SurgiCount Medical, ... Technologies, Inc. (OTCBB:PSTX, OTCQB:PSTX). This system provides a ...
Cached Medicine Technology:HackensackUMC Adopts SurgiCount Safety-Sponge® System 2HackensackUMC Adopts SurgiCount Safety-Sponge® System 3
(Date:11/26/2014)... (PRWEB) November 26, 2014 Increasing ... stringent drug safety regulations are expected to be ... period. Growing prevalence of acute and chronic ailments ... for new drug development. Moreover, growing adverse drug ... the same has become the need of the ...
(Date:11/26/2014)... Gone are the days when throngs of shoppers flood ... signifies the beginning of the Christmas shopping season. Instead, shoppers ... the comfort of their homes or on the go, away ... to be an occasion with one of the fastest growing ... in revenue for online retailers according to Adobe Digital Index. ...
(Date:11/26/2014)... Minneapolis, MN (PRWEB) November 26, 2014 ... Dealer by The Week in Imaging, an online information ... and services. This is the sixth consecutive year Loffler ... in recent years. , The Elite Dealer Awards honor ... dealer community. This year’s Elite Dealer honorees were chosen ...
(Date:11/26/2014)... 2014 GI for Life announced today, ... in prices of their popular nutritional supplements: ColoVite ... . Discounts of 40% will be offered for ... Life’s proprietary ColoVite supplement is a scientifically formulated vitamin ... health. One easy-to-take colon vitamin with ALL the nutrients ...
(Date:11/26/2014)... Schaumburg, IL (PRWEB) November 26, 2014 ... of communication management solutions, has been award the ... Telephony Magazine. , This award comes as a ... its capabilities within the Lync ecosystem. Specifically, ISI ... for all modes of Lync communication, including voice, ...
Breaking Medicine News(10 mins):Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:2014 Best Friday Deals Revealed by Top10InAction 2Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2
... much/too little of the active ingredient , MONDAY, May ... men continue to buy them and experts continue to ... dysfunction. , A new study, conducted in South Korea ... Association annual meeting in San Francisco, finds that not ...
... engine sounds alone, study shows , MONDAY, May 31 ... weekend, diehard race car fans may employ a trick ... difference between the speeding competitors, engines with nothing but ... study from the Indiana University School of Medicine suggests. ...
... ... and Oxfam Ambassador Kylie Kwong is challenging Australians to imagine life cooking recipes with ... ‘Stop Hunger’ Appeal. , ... (PRWEB) May 31, 2010 -- Acclaimed chef, author and Oxfam Ambassador Kylie ...
... cesarean births in British Columbia were a result of maternal ... varied widely across health regions in B.C., according to a ... is a misconception that the overall increase of cesarean births ... Hanley, a PhD student in the UBC School of Population ...
... pain, study finds , SUNDAY, May 30 (HealthDay News) -- ... K" by the young partygoers who use it, is ... urinary incontinence. , The finding is based on a 2009 ... Kong. They questioned 66 male and female teen and young ...
... of Rehabilitation Medicine have made an important discovery that ... Karim Fouad and David Bennett have identified one of ... injury. To help understand the discovery the researchers ... in the spinal cord that control muscle contractions. These ...
Cached Medicine News:Health News:Dangers Lurk in Impotence Drugs Sold on Web 2Health News:Race Car Fans Develop Special Hearing Abilities 2Health News:Kylie Kwong & Oxfam's Recipe to Stop Hunger 2Health News:Kylie Kwong & Oxfam's Recipe to Stop Hunger 3Health News:Regional differences in C-section rate not a result of maternal request: UBC study 2Health News:Club Drug 'Special K' Could Leave Users Incontinent 2Health News:Club Drug 'Special K' Could Leave Users Incontinent 3Health News:U of A discovery offers promising research for spinal-cord injury treatments 2
... LabWeb is a full-featured laboratory information ... only Psyche Systems can deliver - ... and a true partnership. LabWeb features ... lean powerful database for in-depth analysis, ...
PacePath is a comprehensive anatomic pathology software system that is the culmination of more than five years of development and testing by leading industry experts....
... designed to provide optimal speed, efficiency and ... larger network system. Most importantly, EZLink meets ... three workstations located in the same facility ... For creating a paperless laboratory, the network ...
Velocity works cooperatively with LabSofts LabNet LIS, allowing the convenience of 24-hour access to information from satellite lab locations, hospitals, physician offices and even homes....
Medicine Products: